181 related articles for article (PubMed ID: 2568659)
1. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
Halperin R; Guerin JJ; Davis KL
Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
Costall B; Naylor RJ
Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
[TBL] [Abstract][Full Text] [Related]
3. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
Halperin R; Guerin JJ; Davis KL
Life Sci; 1983 Aug; 33(6):585-92. PubMed ID: 6684202
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
Moghaddam B; Bunney BS
J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
7. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
Schremmer C; Morgenstern R; Fink H; Ott T
Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
Robertson A; MacDonald C
Eur J Pharmacol; 1985 Feb; 109(1):81-9. PubMed ID: 4039669
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
Blaha CD; Lane RF
Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
12. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
Arnt J
Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
[TBL] [Abstract][Full Text] [Related]
14. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.
de Belleroche JS; Neal MJ
Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910
[TBL] [Abstract][Full Text] [Related]
15. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.
Hoffman DC
J Neural Transm Gen Sect; 1992; 89(1-2):1-10. PubMed ID: 1358122
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats.
Pfaus JG; Phillips AG
Psychopharmacology (Berl); 1989; 98(3):363-8. PubMed ID: 2568656
[TBL] [Abstract][Full Text] [Related]
18. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
Gattaz WF; Schummer B; Behrens S
J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
[TBL] [Abstract][Full Text] [Related]
19. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs.
Moghaddam B; Bunney BS
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S51-7. PubMed ID: 2097674
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
